← All organizations

Ology Bioservices

For profitWebsite ↗

Also known as: Ology Bioservices

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jun 29, 2022

Acquired by Reslience on Apr 13, 2021

Timeline

2000s

Jun 1, 2000
Ology Bioservices— Founded

2020s

Apr 13, 2021
Reslience— Acquired By

Drugs by trial phase (11 distinct, 36 trials)

Phase 3 (5 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

prx-03140

Indications

Studied for

Recent trials (37)

NCT05348993Lead sponsorPhase 2Jun 29, 2022
NCT05142527Lead sponsorPhase 2/Phase 3Dec 31, 2021
NCT04705844Lead sponsorPhase 3May 31, 2021
NCT04679623CollaboratorPhase 1May 3, 2021
NCT04592549Lead sponsorPhase 1Dec 4, 2020
NCT04171115Lead sponsorPhase 1Apr 1, 2020
NCT03046550Lead sponsorPhase 1Mar 20, 2017
NCT01911754Lead sponsorPhase 3Aug 1, 2013
NCT01774032Lead sponsorPhase 3Mar 1, 2013
NCT01604746Lead sponsorPhase 3Jul 1, 2012
NCT01492699Lead sponsorN/AJun 1, 2012
NCT01492699Study directorN/AJun 1, 2012
NCT01518491Study directorPhase 2Apr 1, 2012
NCT01382329Lead sponsorPhase 2/Phase 3Jun 1, 2011
NCT01242670Lead sponsorPhase 3Apr 1, 2011

Details

Founded: Alachua, FL, US Jun 1, 2000
Last known activity: Jun 29, 2022

Notes

formerly Nanotherapeutics, Inc.